US Stock MarketDetailed Quotes

TBPH Theravance Biopharma

Watchlist
  • 9.855
  • +0.015+0.15%
Trading Dec 4 10:06 ET
484.61MMarket Cap-9567P/E (TTM)

About Theravance Biopharma Company

Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.

Company Profile

SymbolTBPH
Company NameTheravance Biopharma
Listing DateMay 16, 2014
Founded2013
CEOMr. Rick E. Winningham
MarketNASDAQ
Employees99
Fiscal Year Ends12-31
Address901 Gateway Boulevard
CitySouth San
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-650-808-6000
Websitehttp://www.theravance.com

Company Executives

  • Name
  • Position
  • Salary
  • Rick E. Winningham
  • Chief Executive Officer and Chairman of the Board
  • 1.30M
  • Rhonda Farnum
  • Chief Business Officer and Senior Vice President, Commercial and Medical Affairs
  • --
  • Aziz Sawaf
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 583.50K
  • Brett A. Grimaud
  • Senior Vice President, General Counsel and Secretary
  • --
  • Dr. Aine Miller, PhD
  • Senior Vice President, Development and Head of Ireland Office
  • --
  • Donal O’Connor
  • Independent Director
  • 195.80K
  • James C. Kelly
  • Independent Director
  • 43.10K
  • Dean Jonathan Mitchell
  • Lead Independent Director
  • 211.73K
  • Dr. Laurie Smaldone Alsup, M.D.
  • Independent Director
  • 197.68K
  • Dr. Deepika Rachel Pakianathan
  • Independent Director
  • 207.68K
  • Susannah Gray, M.B.A.
  • Independent Director
  • 346.47K
  • Eran Broshy
  • Independent Director
  • 205.14K
  • Jeremy Grant
  • Independent Director
  • 168.36K
Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data